Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- PMSB Proposes NDA Dossier Guide According to CTD
May 14, 2001
- BUSINESS NEWS IN BRIEF -1-
May 7, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF -2-
May 7, 2001
- BUSINESS NEWS IN BRIEF -2-
May 7, 2001
- Takeda Discovers Respiratory Disease-related Genes
May 7, 2001
- Only 2 out of 20 Keidanren Deregulation Proposals Implemented
May 7, 2001
- Short-acting Insulin Analog Treatment Effective in Type 2 Diabetes: JDA/Lilly Seminar
May 7, 2001
- 27 GEs Delisted 1 Year after Application of GE Rule
May 7, 2001
- Many Psychiatrists Dissatisfied with Drugs to Treat Schizophrenia
May 7, 2001
- CSTP Subpanel to Propose Promotion Strategy in Prioritized Fields
May 7, 2001
- OTC NEWS IN BRIEF
May 7, 2001
- PMSB Asks Manufacturers to Stop Supply of Phenacetin
May 7, 2001
- AstraZeneca's Diprivan Inj-Kit to Contribute to Preventing Accidents
May 7, 2001
- REGULATORY NEWS IN BRIEF
May 7, 2001
- Atorvastatin Raises Treatment Target Achievement Rates: Yamanouchi/Pfizer Seminar
May 7, 2001
- Japanese Global Strategy Update (1)
May 7, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF -1-
May 7, 2001
- Pricing Rule for Innovative Medical Devices to Be Studied
May 7, 2001
- DIAGNOSTIC NEWS IN BRIEF
May 7, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF -3-
May 7, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…